Genetic treatments for sickle cell

May 01, 2016

sickle cell disease blood cells

Patients with sickle cell disease with high levels of fetal hemoglobin have a milder course of the disease because the mutation that causes red blood cells to “sickle” resides only in adult hemoglobin. Now researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other centers are looking to gene editing or gene therapy – and eventually a pill – to control the switch to ease the devastating disease, Scientific American reports.

Media Inquiries

Irene Sege
Senior Media Relations Specialist

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo